Net Positive After QCOR Conference Call; Co. Continues To See Acthar Script Approvals
Research - The 48% decline seen for shares of Questcor Pharmaceuticals (NASDAQ:QCOR) Wednesday prompts the key question of: What to do with the stock now? As a … Continue Reading
Read now